Providence Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.42M Sell
31,134
-1,297
-4% -$59.1K 0.97% 36
2025
Q1
$1.93M Buy
32,431
+1,372
+4% +$81.5K 1.46% 21
2024
Q4
$1.77M Buy
31,059
+242
+0.8% +$13.8K 1.34% 23
2024
Q3
$1.63M Buy
30,817
+763
+3% +$40.2K 1.2% 26
2024
Q2
$1.26M Buy
30,054
+552
+2% +$23.2K 1% 35
2024
Q1
$1.56M Buy
29,502
+23,579
+398% +$1.24M 1.33% 22
2023
Q4
$784K Sell
5,923
-21,194
-78% -$2.81M 0.71% 46
2023
Q3
$1.56M Buy
27,117
+204
+0.8% +$11.8K 1.74% 17
2023
Q2
$1.74M Sell
26,913
-1,266
-4% -$81.9K 1.93% 14
2023
Q1
$1.95M Buy
28,179
+153
+0.5% +$10.6K 1.44% 22
2022
Q4
$2.01M Buy
28,026
+80
+0.3% +$5.75K 1.5% 22
2022
Q3
$2.26M Sell
27,946
-90
-0.3% -$7.28K 1.69% 18
2022
Q2
$2.13M Buy
28,036
+989
+4% +$75.2K 1.54% 18
2022
Q1
$2M Buy
27,047
+139
+0.5% +$10.3K 1.28% 26
2021
Q4
$1.74M Buy
26,908
+778
+3% +$50.2K 1.09% 31
2021
Q3
$1.55M Sell
26,130
-781
-3% -$46.3K 1.08% 29
2021
Q2
$1.79M Sell
26,911
-221
-0.8% -$14.7K 1.22% 24
2021
Q1
$1.71M Buy
27,132
+692
+3% +$43.7K 1.26% 23
2020
Q4
$1.64M Buy
26,440
+258
+1% +$16K 1.36% 21
2020
Q3
$1.58M Sell
26,182
-3,213
-11% -$194K 1.56% 18
2020
Q2
$1.73M Buy
29,395
+202
+0.7% +$11.9K 1.76% 17
2020
Q1
$1.61M Buy
29,193
+159
+0.5% +$8.75K 1.94% 18
2019
Q4
$1.86M Sell
29,034
-538
-2% -$34.5K 1.71% 18
2019
Q3
$1.5M Buy
29,572
+1,072
+4% +$54.4K 1.34% 25
2019
Q2
$1.32M Buy
28,500
+612
+2% +$28.4K 1.23% 29
2019
Q1
$1.34M Buy
27,888
+1,437
+5% +$68.8K 1.26% 29
2018
Q4
$1.35M Sell
26,451
-94
-0.4% -$4.79K 1.49% 24
2018
Q3
$1.65M Sell
26,545
-200
-0.7% -$12.4K 1.5% 23
2018
Q2
$1.48M Sell
26,745
-31
-0.1% -$1.72K 1.44% 23
2018
Q1
$1.66M Buy
+26,776
New +$1.66M 2.46% 10